RenovoRx Inc. (RNXT)
NASDAQ: RNXT
· Real-Time Price · USD
1.33
0.03 (2.31%)
At close: Jun 16, 2025, 3:59 PM
1.32
-0.75%
After-hours: Jun 16, 2025, 06:23 PM EDT
2.31% (1D)
| Bid | 1.22 |
| Market Cap | 48.64M |
| Revenue (ttm) | 240K |
| Net Income (ttm) | -10.16M |
| EPS (ttm) | -0.41 |
| PE Ratio (ttm) | -3.24 |
| Forward PE | -4 |
| Analyst | Strong Buy |
| Ask | 1.46 |
| Volume | 84,835 |
| Avg. Volume (20D) | 151,169 |
| Open | 1.35 |
| Previous Close | 1.30 |
| Day's Range | 1.32 - 1.35 |
| 52-Week Range | 0.75 - 1.69 |
| Beta | 1.32 |
About RNXT
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol RNXT
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for RNXT stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts4 months ago
-20.55%
RenovoRx shares are trading lower after the compan...
Unlock content with
Pro Subscription
4 months ago
-2.01%
RenovoRx shares are trading lower after the company announced a proposed public offering.
1 month ago · seekingalpha.com
RenovoRx, Inc. (RNXT) Q1 2025 Earnings Conference Call TranscriptRenovoRx, Inc. (NASDAQ:RNXT ) Q1 2025 Earnings Conference Call May 15, 2025 4:30 PM ET Company Participants Valter Pinto - IR Ramtin Agah - Founder and Chief Medical Officer Shaun Bagai - CEO Ronald K...
2 months ago · businesswire.com
RenovoRx to Present at LD Micro Invitational XV Conference in New York on April 10thMOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--RenovoRx, Inc. (“RenovoRx” or the “Company”) (Nasdaq: RNXT), a life sciences company developing innovative targeted oncology therapies and commercializing Renov...
